Promedica International CME
  • CME Symposia
    • The Houston Aortic Symposium 2023
    • 34th Annual Cardiovascular Interventions
  • Certificates
  • Non-CME
    • Precision PCI 2022
    • Cardiovascular Interventions 2020 On-Demand
  • Services
    • FAQs
    • Quick Quote
  • Exhibiting
    • Upcoming Exhibitor Events
    • Brochures & Flyers
  • About Us
    • Mailing List Sign Up
    • Contact
    • Implicit Bias & Cultural & Linguistic Competency
    • Blog
    • Careers
    • Mission Statement
    • Terms & Conditions
    • Privacy Policy
Select Page

Discussion on PCSK9 Inhibitors

by Richard R. Heuser, MD, FSCAI | Jun 18, 2015 | CDM 2015, Uncategorized | 0 comments

A 65 year old asymptomatic woman sees you for therapy. She has a positive family history of early CV mortality. Her cholesterol is over 400 with intolerance to statins. She carries a diagnosis of homozygous familial hypercholesterolemia (HoFH). What is the role of the...
Promedica International CME
300 Carlsbad Village Dr., Ste 108A-326
Carlsbad, California 92008
Tel: 760-720-2263, Fax: 760-444-3158
© 2016 - . All Rights Reserved.
  • Privacy Policy
  • Terms & Conditions